**Core tip:** The administration of antisecretory and antibacterial drugs can lead to the conversion of *Helicobacter pylori* (*H. pylori*) into the resting (dormant) state. C-shaped and U-shaped forms of *H. pylori*, most likely, are dormant forms of the bacteria. C-shaped and U-shaped forms of *H. pylori* are capable of reverse transition into the vegetative replicative state and of causing development of recurrence of peptic ulcer disease (PUD). The induction of process reversion occurs under the influence of specific molecules. The identification and study of these compounds will allow development of new drugs aimed at preventing recurrent PUD associated with dormant forms of *H. pylori*.

INTRODUCTION
============

Peptic ulcer disease (PUD) is a problem that is traditionally the center of attention of gastroenterologists\[[@B1]\]. Many aspects of this pathology have been well studied. The disease develops as a result of the influence of a set of various exogenous and endogenous etiological factors. There are many theories of PUD development, including vascular, inflammatory-gastritis, allergic, hormonal, motor-primacy, corticovisceral, neurogenic, psychosomatic, acido-peptic and infectious ones. Each of them deserves attention, as it reflects one of the facets of this complex problem. The diversity of the causes that lead to the pathological process allows PUD to be considered as a polyetiologic and polypathogenic disease.

PUD with a frequently recurrent or long-term healing ulcer of the stomach or duodenum generally occurs in the presence of chronic active gastritis or chronic active duodenitis, both of which are associated with *Helicobacter pylori* (*H. pylori*) infection. Decontamination of the gastric mucosa (GM) with various antibiotics results in *H. pylori* eradication and longer remission in PUD\[[@B2]-[@B6]\]. However, the reasons for repeated detection of *H. pylori* in relapsed PUD after its supposedly successful eradication remain unclear. This may be due to either reinfection or ineffective anti-Helicobacter therapy. In most cases, the administration of antibacterial drugs leads to complete *H. pylori* eradication, but can give rise to resistant bacterial strains and facilitate the conversion of *H. pylori* into the resting (dormant) forms\[[@B7]\]. It is therefore relevant to study dormant *H. pylori* forms, as well as their values in ulcerogenesis\[[@B8]\].

*H. PYLORI* IS ONE OF THE ETIOLOGICAL FACTORS OF PUD
====================================================

Landmarks in the history of H. pylori studies
---------------------------------------------

The accumulated scientific data can confirm that *H. pylori* infection is important in the mechanism of PUD development\[[@B9]\]. *H. pylori* was first reported in 1875 when Bottcher and Letulle observed it on the margins of peptic ulcers\[[@B10]\]. The bacterium did not grow in the artificial nutrient media that were known at that time, and this accidental discovery was long forgotten. In the 1980s, Australian pathologist Robin Warren together with Barry Marshall isolated *H. pylori* from human gastric mucosal biopsy specimens and cultured it in artificial nutrient media. Warren and Marshall suggested that most gastric ulcers and gastritis in humans might be associated with *H. pylori* infection\[[@B11],[@B12]\]. Marshall demonstrated the role of *H. pylori* infection in the development of gastrointestinal diseases in 1983. He drank a culture of the bacterium to prove the etiological role of *H. pylori* in the development of antral gastritis. Thereafter, he developed *H. pylori*-associated antral gastritis. After that, many researchers concentrated on the study of *H. pylori*\[[@B13]\].

There has been gradually increasing evidence that duodenal ulcers and duodenitis are also associated with *H. pylori* infection\[[@B14]-[@B16]\]. In 2005, Warren and Marshall received the Nobel Prize in Physiology or Medicine for the discovery of *H. pylori* pathogenicity\[[@B12]\] and rekindled interest in the study of this microorganism. Since then, the association of *H. pylori* with digestive system diseases has been the subject of much research attention\[[@B10],[@B16]\].

Risk of digestive system diseases caused by H. pylori
-----------------------------------------------------

*H. pylori* is one of the most common infections worldwide. *H. pylori* infection is highly prevalent throughout the world, especially in developing countries\[[@B10]\]. Nearly half of the global population are carriers of *H. pylori*, a Gram-negative bacterium that persists in the human stomach and duodenum\[[@B12],[@B17]-[@B21]\]. *H. pylori* gastric colonization is acquired early in life (almost always before the age of 10 years), and, in the absence of antibiotic therapy, generally persists for life\[[@B12],[@B22],[@B23]\]. The prevalence of *H. pylori* ranges from 35% to 90% in different populations\[[@B21],[@B24]-[@B28]\]. It presents in 70%-90% of the population in developing countries and 35%-40% in developed ones\[[@B21],[@B29]\].

Moscow falls into a group of cities with extremely high *H. pylori* infection prevalence, with the predominance of virulent bacterial strains\[[@B30]\]. It is reported that 88% of the Moscow working population is infected with *H. pylori*. Its prevalence is 78% in people younger than 30 years and about 97% in individuals older than 60 years\[[@B30]\]. The prevalence of *H. pylori* infection is high in developing countries, especially among children. In India, the prevalence of this infection is 22%, 56% and 87% in the 0-4, 5-9 and 10-19 year age groups, respectively\[[@B21],[@B31]\]. *H. pylori* is usually the numerically dominant gastric microorganism\[[@B13]\]. However, PUD occurs only in a small percentage of *H. pylori* carriers\[[@B32]\].

*H. pylori* does not typically cause any adverse effects\[[@B13]\]. Many people infected with *H. pylori* are shown to remain asymptomatic carriers\[[@B33]\]. It has turned out that *H. pylori* may behave as a commensal or symbiont, depending upon the circumstances\[[@B34]-[@B37]\]. The idea that *H. pylori* might actually confer benefits to humans has engendered considerable controversy among investigators. The data of the potential importance of health benefits that might be afforded by *H. pylori* are considered and debated in the review by Cover and Blaser\[[@B13]\]. It has been presumed that the conserved microbiota have specific adaptations that permit persistence at particular locales\[[@B13]\].

In the 1980-1990s, researchers studied the role of *H. pylori* as an important factor in the etiopathogenesis of PUD. Human gastric colonization by the bacterium *H. pylori* is a predisposing factor for gastrointestinal diseases, such as gastritis and PUD\[[@B13],[@B38]\]. Strong links exist between PUD and *H. pylori* infection\[[@B39]\]. So, *H. pylori* detection rates in PUD vary from 60% to 100%. There is also a strong relationship between *H. pylori* and duodenal ulcer\[[@B21]\]. *H. pylori* has been shown to be one of the important local factors involved in the development of ulcerative defect\[[@B40],[@B41]\]. The manifestations associated with chronic *H. pylori* infection vary considerably among distinct geographic regions and these differences have been attributed at least in part to polymorphisms of *H. pylori* genes, particularly those encoding virulence factors\[[@B15]\]. *H. pylori* is an important gastrointestinal pathogen associated with gastritis, PUD, and an increased risk of gastric carcinoma\[[@B22]\]. The presence of *H. pylori* in the gastroduodenal mucosa and its involvement in the development of chronic gastritis, PUD, carcinoma and other diseases are well documented\[[@B9],[@B15],[@B23],[@B42]\].

Blaser considers that *H. pylori* shows its pathogenicity, by regulating the expression of different genes to the extent that is dictated by the response of a macroorganism\[[@B13],[@B43]\]. The microorganism and macroorganism create a finely tuned balance system, the resulting impairment of which develops a specific disease with certain clinical signs and prognosis\[[@B44]\]. In the vast majority of cases, long-lasting *H. pylori* infection induces chronic gastritis, while only some patients develop PUD and gastric cancer. For this reason, the bacterium is considered to be a risk factor for the development and recurrence of PUD\[[@B45],[@B46]\]. Therefore, *H. pylori* is assigned to the group of pathogenic bacteria. Antibiotic treatment of PUD results in bacterial disappearance and ulcer healing\[[@B12]\]. Marshall and Warren reported that eradication of the bacteria significantly reduced the duodenal ulcer relapse rate\[[@B12]\].

Characteristics of H. pylori
----------------------------

The genus *Helicobacter* (helix and bacteria) is heterogeneous\[[@B47]\]. The *Helicobacter* genus now includes at least 26 formally named species, and more that are still being studied\[[@B48],[@B49]\]. Some of them were previously known by other names. Humans have been found to have only 11 *Helicobacter* species: *H. pylori*, *H. heilmannii*, and *H. felis* in the GM, *H. cinaedi* (*H. westmeadii*, *H. canadensis*), *H. fennelliae*, *H. canis*, *H. pullorum*, and *H. rappini* in the small intestinal mucosa. Some *Helicobacter* species have been isolated from the human hepatobiliary system: *H. pylori* from the liver, *H. bilis*, *H. pullorum*, and *H. rappini* from the bile ducts. *H. pylori* is the best known bacterium. *H. pylori* includes several strains\[[@B46]\]. *H. pylori* strains isolated from unrelated humans exhibit a high level of genetic diversity (reviewed in Blaser MJ and Berg DE\[[@B50]\]). The genetic structure of the pathogenic genes of *H. pylori* varies largely, which contributes to the differences in virulence among various strains and in clinical symptoms\[[@B15]\]. *H. pylori* strains differ in resistance to drugs, adhesive specificity and production of cytotoxins.

*H. pylori* (Figure [1](#F1){ref-type="fig"}) is a small, Gram-negative, asporogenous, S-shaped or slightly spirally curved, microaerophilic bacterium\[[@B51]-[@B53]\].

![Morphology of *Helicobacter pylori*. S-shaped *H. pylori* with five to seven sheathed polar flagella. Field emission SEM, bar = 0.5 μm. (Field emission SEMs courtesy of L. Thompson and negative stains courtesy of S. Danon, School of Microbiology and Immunology, University of New South Wales). From: *Helicobacter pylori*: Physiology and Genetics. Mobley HLT, Mendz GL, Hazell SL, editors. Washington (DC): ASM Press; 2001. Chapter 6, Morphology and Ultrastructure\[[@B54]\].](WJG-23-4867-g001){#F1}

Thirty-seven degrees Celsius and pH 4.0-6.0 are the most favorable conditions for the life, growth, and reproduction of *H. pylori*; although, the species also survives at pH 2.5. *H. pylori in vivo* and under optimum *in vitro* conditions exists as an S-shaped bacterium with 1 to 3 turns, 0.5 μm × 5 μm in length, and a tuft of 5 to 7 polar sheathed flagella\[[@B54]-[@B56]\]. The bacterial cell is covered with a smooth sheath. The flagellum of *H. pylori* is 30 nm in diameter, consisting of an internal filament approximately 12 nm in diameter surrounded by a sheath, the outer membrane of which is continuous with the outer membrane of the cell\[[@B54]-[@B56]\].

Unipolar flagella are essential for the unique motility of *H. pylori*\[[@B57]\]. Qin et al\[[@B57]\] employed cryo-electron tomography to visualize intact *H. pylori* cells, with a particular focus on the flagella. Remarkably, the unipolar flagella of *H. pylori* are driven by one of the largest flagellar motors found in bacteria. The flagellar motor provides higher torque needed by the bacterium to navigate the viscous environment of the human stomach. Thin sections of *H. pylori* reveal the typical cell wall detail of a Gram-negative bacterium that consists of outer and inner, or plasma, membranes separated by the periplasm of approximately 30 nm thickness\[[@B54]\]. *H. pylori* has inherent corkscrew motility. The presence of flagella, a smooth cell sheath, a spiral shape, and corkscrew motility allows this microorganism to move in the mucus thickness along the pH gradient and serves as its virulence factor. In addition, the flagella contribute to the aggregation of *H. pylori* to colonize the latter on the epithelial surface of GM\[[@B58]\].

The stomach is the major habitat of *H. pylori*\[[@B13]\], but it may also survive in other environments\[[@B13],[@B18],[@B59]\]. The habitat of *H. pylori* may be the proximal duodenum or distal esophagus. This is usually accompanied by gastric metaplasia at these sites\[[@B13]\]. A gene that is pathognomonic for duodenal ulcer and called *dupA* (duodenal ulcer promoting gene), which encompasses the two *H. pylori* genes of *jhp0917* and *jhp0918*, has been discovered\[[@B60]\]. This gene increases the survival of the microorganism at low pH values. The presence of the *dupА* gene is associated with a high risk for duodenal ulcer and with a low risk for gastric atrophy and cancer\[[@B61]\].

COCCOID AND DORMANT FORMS OF *H. PYLORI*
========================================

Morphological forms of H. pylori
--------------------------------

All living organisms are equipped with mechanisms that allow extended survival in adverse environments. For a number of them, this response involves, besides metabolic adaptations, changes in cell morphology\[[@B62]\]. *H. pylori* is mainly present as a spiral-shaped form in human gastric biopsy specimens. On aging, the bacterial cells lose their typical spiral-shaped form and convert to coccoid ones (Figure [2](#F2){ref-type="fig"})\[[@B54]\]. When influenced by adverse factors (temperature or pH changes, prolonged fasting when cultivated, or use of antibacterial drugs), non-spore-forming microorganisms can be transformed into a latent coccoid form\[[@B63]\].

![Microscopic images of coccoid forms of *Helicobacter pylori* after 6-d exposure to antibiotics. From: Faghri et al\[[@B65]\].](WJG-23-4867-g002){#F2}

The ability of *H. pylori* to transform from the spiral-shaped form to the coccoid form is one of its most important, but not exclusive properties. Through the course of evolution, *H. pylori* has evolved special adaptive mechanisms and acquired vital physiological properties allowing it to survive extreme situations in the human organism, when cultivated, and to survive in the external environment\[[@B64]\].

The bacterium transforms from spiral to coccoid under mild circumstances, whereas under extreme ones it is unable to undergo shape modification. This strongly supports the view that transformation into the coccoid form is an active, biologically led process, switched on by the bacterium as a protection mechanism\[[@B62],[@B65]\]. This study demonstrates that the coccoid shape is in fact a manifestation of cell adaptation to less than optimum environments.

Saito et al\[[@B66]\] identified three types of coccoid forms of *H. pylori*. The authors claim to represent different *H. pylori* transformation processes and consist of bacteria that are dead, living and cultivated, and viable but non-culturable\[[@B62],[@B66]\]. Controversy exists as to whether these cells are viable, dormant or just dead\[[@B54]\].

The initial stage of *H. pylori* transformation in the coccoid form is accompanied by the condensation of the protoplasmic matrix and an increase in the periplasm on one side of the microorganism (usually at the pole opposite to the flagellar basal complex). An increase in the volume of the periplasmic space leads to stretching of the cell wall, displacement of the protoplasmic matrix to the periphery, and accumulation of dense material, that results in the formation of C-shaped and/or U-shaped cells (Figure [3](#F3){ref-type="fig"})\[[@B54]\].

![Microscopic images of morphological forms of *Helicobacter pylori* after exposure to antibiotics: S-shaped, U-shaped, C-shaped and coccoid-shaped. From: Faghri et al\[[@B65]\].](WJG-23-4867-g003){#F3}

These C-shaped and/or U-shaped forms then convert to the coccoid cells, with an increase in the protoplasmic cylinder and maintenance of the double membrane system (Figures [3](#F3){ref-type="fig"} and [4](#F4){ref-type="fig"})\[[@B54]\]. In their work, Mouery et al\[[@B67]\] have shown transmission electron micrographs of typical stages of the helical-to-coccoid transformation. C-shaped and/or U-shaped forms of *H. pylori* are an intermediate state of the bacteria\[[@B67]-[@B69]\].

![Electronograms of coccoid forms of *Helicobacter pylori*. A: Initial ingrowth in the periplasmic space resulting in the formation of U-shaped cells; B: Conversion to the coccoid form. Ultrathin section, bar = 0.5 μm. From: *Helicobacter pylori*: Physiology and Genetics. Mobley HLT, Mendz GL, Hazell SL, editors. Washington (DC): ASM Press; 2001. Chapter 6, Morphology and Ultrastructure\[[@B54]\].](WJG-23-4867-g004){#F4}

The C-shaped and/or U-shaped forms of *H. pylori* are an intermediate bacterial type transforming into an inactive phase (dormancy). Dormancy is understood to be a reversible state of bacterial cells with a low metabolic activity, in which they can be for a long time without replication\[[@B63],[@B70],[@B71]\]. In microbiology, this condition has, until recently, been associated with the presence of forms, such as spores and cysts. In the late 20^th^ century, the literature began to discuss the possibility of formation of dormant (resting) forms by non-spore-forming bacteria\[[@B63],[@B72]\] that encompass most Gram-negative pathogenic bacteria, including *H. pylori*. Dormancy is characterized by the increased resistance of bacterial cells to extreme stresses (deficiency of nutrients, effects of antisecretory drugs, antibiotics, *etc*.) and favors their survival\[[@B73]\]. The ability of *H. pylori* to go into a dormant state may be an important factor in the epidemiology and spread of helicobacteriosis. The C-shaped and U-shaped forms of *H. pylori* can be considered truly a dormant form capable of reinfection\[[@B53]\]. The role of these forms in the pathogenesis and transmission of infection needs to be clarified.

The C-shaped and/or U-shaped forms of *H. pylori* keep the polar membrane associated with the flagellar basal complex\[[@B56],[@B65]\]. Only a small number of intermediate forms of *H. pylori* possesses a complete set of flagella and retains metabolic activity to ensure mobility comparable to that of spiral-shaped forms\[[@B68]\].

The fully-formed coccoid forms maintain the basic pattern of a bacterial cell structure (Figure [4](#F4){ref-type="fig"}). They have a cell wall, cytoplasmic membrane and cytoplasm\[[@B56],[@B62],[@B67],[@B69],[@B74]\]. The coccoid cells differ in details of the cell wall structure, which leads to impairment of recognition of the bacteria by the host immune system (bacterial mimicry)\[[@B68]\].

The accumulated scientific data suggest that there are three morphological forms of *H. pylori*: (1) S-shaped forms; (2) U-shaped and C-shaped (intermediate or transitional) forms; and (3) Coccoid forms.

The intermediate and coccoid forms can coexist in the mucosa or in the culture in various ratios\[[@B75]\]. Their ratio depends on the time of *H. pylori* being present under adverse conditions and on the level of exposure to adverse factors. Spiral-shaped forms were predominant in a 3-d culture of *H. pylori*; about half of the bacteria are coccoid forms at 6 d\[[@B76]-[@B78]\]. Mouery et al\[[@B67]\] show the graphical distribution of the ratio of morphological forms of *H. pylori* after 12, 24 and 48 h of cultivation. The distributions of morphologies of more than 100 cells of each genotype for each time point are shown\[[@B67]\]. The number of coccoid forms increases with the longer time of cultivation. This happens due to the transition of C-shaped and U-shaped forms of *H. pylori* to coccoid ones.

The C-shaped, U-shaped and coccoid forms of *H. pylori* lose enzyme activity and show a lower metabolism\[[@B79]\]. The urease activities of resting (dormant) and coccoid cells were found to be lower than those of the spiral-shaped form of *H. pylori*\[[@B80],[@B81]\]. A significant transformation of *H. pylori* into coccoid forms may result in loss of urease activity. However, urease-encoding genes continue to be identified in *H. pylori* by polymerase chain reaction (PCR)\[[@B69],[@B81],[@B82]\]. The minimization of enzyme activity and energy metabolism in the transformable *H. pylori* forms is adaptive and aimed at preserving the viability of microorganisms\[[@B65],[@B83]\]. Bacterial viability has been confirmed by the fact that the transformed forms of *H. pylori* can be detected by acridine orange staining\[[@B69],[@B84]\]. The C-shaped, U-shaped and coccoid forms of *H. pylori* tolerate a wider pH range to a greater extent than the spiral-shaped forms, are resistant to unfavorable factors and antibiotics, and cannot lose virulence. All this creates favorable conditions for the preservation of bacteria in the human body or in the external environment.

The triggers of *H. pylori* transformation from spiral-shaped to coccoid forms in the environment may be physical factors: higher insolation, low humidity, and lack of food substrates\[[@B77],[@B85]\]. During bacteriological cultivation, transformation into the coccoid forms occurs due to the depletion of adequate components of the nutrient medium\[[@B85],[@B86]\]. *H. pylori* transforms in the human body due to changes in the habitat conditions upon exposure to antisecretory and antibacterial drugs. Khomeriki et al\[[@B69]\] have studied the time course of changes in the transformation of *H. pylori* in the GM. They have indicated that the spiral-shaped forms transform into the coccoid ones a few hours after adhesion to the cell surface of GM cells\[[@B69]\].

The conversion of the spiral forms of *H. pylori* to its C-shaped, U-shaped and coccoid forms in the GM and in the nutrient medium is due to the accumulation of toxic metabolic products of *H. pylori* vital functions. Reactive oxygen species generated by phagocytes or by *H. pylori* itself in the presence of specific pyridine nucleotides may trigger the formation of transitional and coccoid forms in the GM of untreated patients\[[@B69]\]. When an unfavorable situation occurs, there is accumulation of factors that induce the conversion of cells in the bacterial populations to a dormant state.

Loginov et al\[[@B8]\] carried out a comparative analysis in which *H. pylori* in GM biopsy specimens from patients with duodenal ulcer was detected by a quantitative urease test and PCR before and a month after anti-Helicobacter therapy. Prior to anti-Helicobacter therapy, the detection rate of *H. pylori* in the GM biopsy specimens from patients with PUD was 93.4% and 98.7%, as shown by the quantitative urease test and PCR, respectively (Table [1](#T1){ref-type="table"}). The difference of 5.3% in the detection rate of *H. pylori* may be due to the different sensitivities of these methods.

###### 

Detection of *Helicobacter pylori* in gastric mucosa biopsy specimens from in-patients with duodenal ulcer by quantitative urease test and polymerase chain reaction before and one month after anti-Helicobacter therapy

  **Detection of *Helicobacter pylori***   **Quantitative urease test**   **PCR**   **Difference between methods**
  ---------------------------------------- ------------------------------ --------- --------------------------------
  Before treatment, %                      93.4                           98.7      5.3
  After treatment, %                       11.1                           24.1      13.0

PCR: Polymerase chain reaction.

One month after eradication therapy, these patients had *H. pylori* detected by the quantitative urease test in 11.1% of cases and by PCR in 24.1%. The difference between the methods was 13%, *i.e*., almost twice that as before the treatment. These findings suggest that *H. pylori* were not completely eliminated in some patients at 1 mo after the anti-Helicobacter therapy, and the *H. pylori* diagnosed by PCR were at least partially in a dormant (resting) state and partly in coccoid forms. The low urease activity (or lack thereof) of coccoid *H. pylori* forms precludes identifying them by the quantitative urease test. The data presented allow us to indirectly suggest that after anti-Helicobacter therapy, the dormant forms of *H. pylori* are present in patients as a result of their incomplete elimination\[[@B7],[@B87]\].

Viability of dormant and coccoid forms of H. pylori
---------------------------------------------------

The pleiomorphic nature of *H. pylori* has been the subject of intensive debate for many years, with part of the scientific community arguing that the coccoid shape represents a degraded, nonviable form of the cell\[[@B62],[@B85],[@B86],[@B88]-[@B91]\]. Evidence supporting the concept that the coccoid forms are degenerate and not capable of growth comes from a number of studies showing that as the cells age, the levels of DNA and RNA and mRNA expression decrease with degradation of the nucleic acids, nonrandom fragmentation of the ribosomal RNA, and no evidence of a membrane potential necessary for processes such as oxidative phosphorylation\[[@B54]\]. There is evidence that the coccoid forms lose their reproductive ability, are unculturable in artificial nutrient media, have no characteristic features under a light microscope, and do not produce urease or produce it in low amounts\[[@B65],[@B79],[@B81],[@B86],[@B92],[@B93]\]. The infectivity of coccoid *H. pylori* forms is still controversial\[[@B94]\].

There are opposing data regarding the viability of the C-shaped, U-shaped and coccoid form of *H. pylori*. A study by Khomeriki and Morozov\[[@B69]\] indicated that the structural transformation of spiral-shaped forms of *H. pylori* into the coccoid forms is not always a sign of functional disintegration of the microorganism. There is evidence confirming the viability of the transformed forms of *H. pylori*\[[@B81]\]. They maintain cell structure, exhibit respiratory activity, support protein metabolism and expression, and, in some cases, are capable of reverse transition into the vegetative spiral-shaped bacteria (on their passage through animals)\[[@B92]\]. Cell respiration is detected in up to 40% after 45 d *in vitro* cultivation of *H. pylori*\[[@B54],[@B95]-[@B97]\]. The findings of Poursina et al\[[@B94]\] suggest that the induced coccoid form of *H. pylori* is not a passive entity but can actively infect a human by expression of the virulence genes after a long stay in the stomach and may contribute to the development of chronic and severe disease. Flow cytometry analyses show that the majority of the induced coccoids (90%-99.9%) are viable\[[@B94]\].

There is evidence of the viability of the transformed forms of *H. pylori* obtained using biochemical methods. The cultures consisting of intermediate and coccoid forms have been found to retain oxidative metabolism at the same level as spiral-shaped forms for several months\[[@B98]\]. They maintain a high level of alkaline and acid phosphatases and a stable ATP level that increases if a number of fresh nutrient medium is added to the old culture\[[@B80]-[@B82],[@B99]\]. Incorporation of a bromodeoxyuridine label into the transformed forms is suggestive of their continuing synthesis of new DNA\[[@B65],[@B69]\]. So far, it is unconfirmed whether these data indicate the viability of *H. pylori* or the persistence of cells as ''bags of enzymes''\[[@B98]\].

The contradictory data on the viability of the transformable forms of *H. pylori* are likely due to the fact that *H. pylori* coexists in coccoid and transitional (intermediate C-shaped and U-shaped) forms under unfavorable conditions in the human body or culture media. It is impossible to isolate data on the viability of intermediate and coccoid forms co-existing in the same culture. Apparently, one part of transformed cells in the population of *H. pylori* truly is degenerative, dead cells\[[@B100]\] (most likely it is the coccoid forms), and the other is dormant cells, reversible forms (most likely it is the C-shaped and U-shaped forms). There is evidence confirming the concept of viability of *H. pylori* dormant forms that indicate saving of cellular integrity and DNA synthesis in 3-mo-old cultures\[[@B54]\].

Available literature data may suggest the existence of the following conditions for various forms of *H. pylori* (Figure [5](#F5){ref-type="fig"}): (1) Viable and culturable (spiral-shaped forms of *H. pylori*) states; (2) Dormant (resting) and culturable (most likely it is the C-shaped and U-shaped forms of *H. pylori*) states; and (3) Non-viable and unculturable (most likely it is the coccoid forms of *H. pylori*) states.

![Major physiological states and forms of *Helicobacter pylori*\[[@B101]\]. *H. pylori*: *Helicobacter pylori*.](WJG-23-4867-g005){#F5}

However, there are not enough solid data to associate the particular morphological type (C-shaped, U-shaped and coccoid forms) of *H. pylori* with the functional characteristics of viability and culturability\[[@B65]\]. As a rule, the literature presents data on the viability of either spiral or coccoid forms. When describing the latter, the presence of dormant (transitional, intermediate, resting) forms is not generally taken into account. The C-shaped and U-shaped forms of *H. pylori* are most likely in a dormant (resting) state and can be a viable and culturable (Figure [5](#F5){ref-type="fig"})\[[@B101]\].

And if so, once under favorable conditions, the dormant (resting) forms of *H. pylori* can revert to a vegetative spiral-shaped form. By using electron microscopy, Konstantinova et al\[[@B102]\] have shown that there are various defects in the cell wall of the transformed forms of *H. pylori*. The authors point out that before the reversion of the dormant forms of *H. pylori* to vegetative forms, there is a need for certain conditions for the repair of cellular damages.

"Reanimated" *H. pylori* can play an important role in the development of recurrent PUD after anti-*Helicobacter* treatment\[[@B81],[@B96]\]. The "revived" forms of *H. pylori* are able to colonize the GM to subsequently develop peptic ulcer relapse\[[@B78],[@B95]\]. Continuation of investigations in this area may reveal new important aspects of the pathogenesis of *H. pylori* infection and to find new ways to treat diseases associated with this microorganism\[[@B69],[@B89],[@B96]\].

Figure [5](#F5){ref-type="fig"} suggests a classification of major physiological states and forms of *H. pylori* that is a hypothetical scheme and requires further evidence. Existing conflicting data on viability and culturability of various forms of *H. pylori* fit well with this scheme and pass into the category of comparable data.

DORMANT FORMS OF *H. PYLORI* IN THE DEVELOPMENT OF RECURRENT PUD
================================================================

The main challenge is to prove the reversion of transformable forms of *H. pylori* into a normal replicative state. There is still no clear separation between the true "revivals" of transformed forms of *H. pylori* that are usually present in the population and secondary infection with the microorganism.

Genetic typing of the same strain of the microorganism has become possible with advances in molecular diagnosis. By using the PCR-based restriction fragment length polymorphism (PCR-RFLP) analysis, *H. pylori* strains in patients with duodenal ulcer were genotyped before and 1 mo after anti-Helicobacter therapy with incomplete elimination\[[@B7],[@B8],[@B87],[@B103],[@B104]\]. The *flaA* gene (1.5 kb in size) encoding the flagellar protein is one of the polymorphic ones in *H. pylori*. This gene is used in genetic typing of *H. pylori* strains. Identical *H. pylori* strains were detected in the same patient before and after the anti-Helicobacter therapy. At that, heterogeneous *H. pylori* strains were found in different patients. The given data suggested that there was neither superinfection nor reinfection with a new strain at 1 mo after anti-Helicobacter therapy.

Warren and Marshall reported that eradication of the bacteria markedly reduced the relapse rate of duodenal ulcer\[[@B12]\]. *H. pylori* eradication decreases the recurrence rate of PUD from 50% to 0%-10% of cases per year\[[@B105]\]. Current treatment modalities allow eradication of the *H. pylori* bacterium in up to 90% of cases (less if there is clarithromycin resistance)\[[@B106]\]. During the first years after effective anti-Helicobacter therapy, the rate of *H. pylori* reinfection in adults is 0%-35%\[[@B107]\]. The rate of *H. pylori* reinfection varies according to geographical area\[[@B106]\]. Reinfection in developed countries is less common, in 0%-7% of cases\[[@B108]\]. In regions with higher socioeconomic status and lower prevalence of *H. pylori*, it is only 1.68% of cases\[[@B106]\]. The *H. pylori* reinfection rate in Lithuania is relatively high (the annual rate being 3.36%), probably because of the high prevalence of *H. pylori*\[[@B105]\]. This could indirectly reflect differences in the socioeconomic status between Western and Eastern European countries\[[@B106]\]. In contrast, in developing countries, the reinfection rate could be much higher and has been reported to reach 9.63%\[[@B106],[@B109],[@B110]\].

In some cases, recrudescence or reinfection of *H. pylori* may occur\[[@B106]\]. According to Loginov et al\[[@B7]\], 18.4% of *H. pylori*-positive patients were identified among those with *H. pylori*-associated duodenal ulcer a year after successful treatment. The recurrence rate of PUD in these patients was 14.3%, which comprised 2.6% of the total number of patients included in the study patients. Reinfection of *H. pylori* is observed rarely and occurs during later periods. Reinfection is considered when *H. pylori* is found after confirmed *H. pylori* eradication. *H. pylori* strains genetically different from the original ones are generally identified in reinfection.

PCR-RFLP was used to detect *H. pylori* strains in patients with duodenal ulcer before and 1 year after anti-Helicobacter therapy\[[@B7],[@B103],[@B104]\]. *H. pylori* strains were genotyped by the *flaA* gene. Genetic typing of *H. pylori* strains revealed both cases of the same strain of the bacterium in a patient before and 1 year after anti-Helicobacter therapy, as well as cases of its different strains. Gastroduodenoscopy (EGD) at 1 year after treatment revealed that all *H. pylori*-positive patients had a pattern of exacerbation of chronic antral gastritis. At that, 1 mo after anti-*Helicobacter* therapy, these patients were found to have no signs of any gastric and duodenal changes during EGD.

Identification of the pattern of chronic antral gastritis and different strains of the bacterium a year after anti-Helicobacter therapy performed in patients with duodenal ulcer could reveal a case of reinfection with a new *H. pylori* strain in the patient successfully treated against *H. pylori*. Identification of the pattern of chronic antral gastritis and the same strain of *H. pylori* a year after anti-Helicobacter therapy in patients with duodenal PUD most likely suggests that the bacterium is transformed from a dormant (resting) state into the vegetative form. Hence, for successful therapy, it is essential not only to eradicate the spiral forms of *H. pylori*, but to eliminate its viable dormant forms.

Factors contributing to the transformation of dormant (resting) forms of bacteria into the vegetative ones
----------------------------------------------------------------------------------------------------------

Mukamolova et al\[[@B111]\] have identified specific bacterial cytokines from *Mycobacterium tuberculosis*, *Mycobacterium avium*, *Micrococcus luteus*, *etc*., and showed their important role in the activation and reproduction of the dormant forms of the bacterium\[[@B111]-[@B114]\]. Cultivation of *M. luteus* in the presence of a small number of colony-forming cells in the starving population has been ascertained to greatly facilitate the resuscitation of dormant cells\[[@B115]\]. The authors have suggested that the viable cells are able to secrete certain substances promoting the transition of dormant forms into an active reproduction state\[[@B111],[@B112],[@B116]\]. A 16-17 kDa protein, named resuscitation-promoting factor (Rpf), has been isolated\[[@B112]-[@B115]\]. The protein promoted the "revival" of the starving cells and reduced the lag phase of an active culture in both the depleted and enriched nutrient media. Using *M. luteus* as an example, Rpf has been shown to stimulate the "reanimation" of dormant cells. Rpf is a pheromone and belongs to the bacterial cytokines\[[@B111]\].

Structural changes in the reversion of coccoid forms of *H. pylori* in the vegetative state have not been studied and their triggers are unknown. There is no evidence that there are cytokine factors for the activation of *H. pylori* reversion and growth. The slightly acidic environment (pH of 5 to 3.5) is known to be a factor that activates the process of protein synthesis in *H. pylori*. Interestingly, in acting on coccoid and spiral-shaped forms, the same acidic pH values induce the synthesis of various proteins in them\[[@B78],[@B117]\]. Some of the *H. pylori* proteins, heat shock protein (Hsp) in particular, have a trophic effect on the bacteria themselves and can cause rearrangement of the cell cytoskeleton, which may be a trigger for the reverse transformation of dormant forms into vegetative ones. Hsp synthesis is enhanced under the influence of a number of environmental factors.

These subcellular proteins belong to the chaperones essential for viability of the entire cellular profile of proteins involved in the processes of assembling for a variety of high-molecular-weight proteins\[[@B118]\]. *H. pylori* possesses two of the most studied chaperones: HspA (smaller) and HspB (larger), which are associated with urease assembling. HspA differs in its properties from analogous proteins of other bacteria. Being strong antigens, *H. pylori* chaperones take a certain part in the activation of lymphocytes, the regulation of cytokine and chemokine expression, the induction of apoptosis, *etc*. However, heat shock proteins play a much more important role in the induction of an autoimmune response due to the fact that they are highly antigenically similar to the orthologic structures of the GM\[[@B119]\]. It is possible that cytokine factors of the macroorganism can play an important role in the activation of bacterium dormant forms.

CONCLUSION
==========

It is necessary to continue studies aimed at identifying specific cytokines or other metabolites of *H. pylori*, which are able to activate the transition of dormant forms of the microorganism into the vegetative spiral state. This will be able to design new anti-Helicobacter drugs to prevent the activation of dormant *H. pylori* forms, as well as recurrent duodenal ulcer.
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